Focusing on tau pathology, a recent study showed KL-VSHET+ to be associated with both lower levels and slower rate of change in amyloid-related increase of tau-PET accumulation in asymptomatic and symptomatic elderly participants, supporting a protective effect of KL-VSHET+ on the primary AD pathologies [32]. The gene discussed is MAPT; the disease is Alzheimer disease.